Arteriovenous Fistula Cannulation Practices and Dialysis Adequacy

NCT04270292 | Completed Results

• 1 other identifier: P0139R00
• Study Type: observational
• Target: 164
• Locations: 1 country
• Sites: 1

Brief Summary

Arteriovenous fistulae are preferred among methods of providing blood access for hemodialysis. For each hemodialysis treatment, the fistula is cannulated usually with two needles. One, the arterial needle, allows the blood to be withdrawn from the patient into the dialysis circuit and then it is returned by the second or venous needle. The success of arteriovenous fistula cannulation is dependent on many variables and these are affect the dialysis adequacy.

Conditions

Arteriovenous Fistula; Hemodialysis; Dialysis Adequacy

Keywords

Arteriovenous fistula; Antegrade direction; Dialysis adequacy; Nursing care; Cannulation practices

Outcome Measures

Primary Outcomes (4)

• Number of Fistula Needle Direction

  The hemodialysis nurse who cannulate the patient's fistula fill the data form. There is two options about fistula direction as antegrade or retrograde.

  up to 12 weeks

• Number of Cannulation Method

  The hemodialysis nurse who cannulate the patient's fistula fill the data form. There is three options about cannulation method as puncture, buttonhole, and rope ladder methods.

  up to 12 weeks

• Number of Fistula Needle Rotated

  The researchers look to the fistula needle while it inserts to the fistula. There is two options as needle rotation is yes or no.

  up to 12 weeks

• Number of Arterial and Venous Needle Been on the Same Line

  The researchers look to the arterial and venous line whether they are the same venous line.

  up to 12 weeks

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Being on hemodialysis therapy for 4 hours a day on 3 days per week for at least 6 months and 18 and older years of age who has arteriovenous fistula

You may qualify if:

• and older years of age
• Have arteriovenous fistula
• Being on hemodialysis therapy for 4 hours a day on 3 days per week for at least 6 months
• Volunteering to participate in the study
• Have not communication problem

You may not qualify if:

• Younger than 18 years old
• Not volunteering to participate in the study
• Have communication problem
• Being on shorter hemodialysis therapy for 4 hours a day on 3 days per week for at least 6 months

Sponsors & Collaborators

• Istanbul Demiroglu Bilim University: lead

Study Sites (1)

Demiroglu Bilim University

Istanbul, Sisli, 34360, Turkey (Türkiye)

Location

Related Publications (4)

• Coventry LL, Hosking JM, Chan DT, Coral E, Lim WH, Towell-Barnard A, Twigg DE, Rickard CM. Variables associated with successful vascular access cannulation in hemodialysis patients: a prospective cohort study. BMC Nephrol. 2019 May 31;20(1):197. doi: 10.1186/s12882-019-1373-3.

  PMID: 31151432 BACKGROUND

• Elias M, Nnang-Obada E, Charpentier B, Durrbach A, Beaudreuil S. Impact of arteriovenous fistula cannulation on the quality of dialysis. Hemodial Int. 2018 Jan;22(1):45-49. doi: 10.1111/hdi.12539. Epub 2017 Mar 6.

  PMID: 28263032 BACKGROUND

• Gauly A, Parisotto MT, Skinder A, Schoder V, Furlan A, Schuh E, Marcelli D. Vascular access cannulation in hemodialysis patients - a survey of current practice and its relation to dialysis dose. J Vasc Access. 2011 Oct-Dec;12(4):358-64. doi: 10.5301/JVA.2011.8413.

  PMID: 21688239 BACKGROUND

• Ozen N, Aydin Sayilan A, Sayilan S, Mut D, Akin EB, Ecder ST. Relationship between arteriovenous fistula cannulation practices and dialysis adequacy: A prospective, multicenter study. J Ren Care. 2022 Mar;48(1):41-48. doi: 10.1111/jorc.12365. Epub 2021 Jan 25.

  PMID: 33492745 DERIVED

MeSH Terms

Conditions

Arteriovenous Fistula

Condition Hierarchy (Ancestors)

Arteriovenous Malformations; Vascular Malformations; Cardiovascular Abnormalities; Cardiovascular Diseases; Vascular Fistula; Vascular Diseases; Congenital Abnormalities; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Fistula; Pathological Conditions, Anatomical; Pathological Conditions, Signs and Symptoms

Results Point of Contact

• Title: Nurten OZEN
• Organization: Demiroglu Bilim University

ozenurten@yahoo.com.tr

+90 (212) 275 75 82

Study Officials

• Nurten Ozen, Asst. Prof.

  Istanbul Demiroglu Bilim University

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: No
• Restrictive Agreement: No

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor

Study Record Dates

• First Submitted: February 12, 2020
• First Posted: February 17, 2020
• Study Start: May 1, 2019
• Primary Completion: December 1, 2019
• Study Completion: January 30, 2020
• Last Updated: September 1, 2020
• Results First Posted: May 22, 2020

Record last verified: 2020-08

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)